openPR Logo
Press release

Investigation announced for Investors in NASDAQ: CRMD shares over potential Wrongdoing at CorMedix Inc.

10-15-2021 03:55 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of current long term investors in CorMedix Inc. (NASDAQ: CRMD) shares.

An investigation on behalf of current long term investors in CorMedix Inc. (NASDAQ: CRMD) shares.

An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of CorMedix Inc..

Investors who are current long term investors in CorMedix Inc. (NASDAQ: CRMD) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NASDAQ: CRMD stocks follows a lawsuit filed against CorMedix Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: CRMD stocks, concerns whether certain CorMedix directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the District of New Jersey the plaintiff alleges that, the Defendants made material misrepresentations concerning the following: (i) deficiencies existed with respect to DefenCath's manufacturing process and/or at the facility responsible for manufacturing DefenCath; (ii) in light of the foregoing deficiencies, the FDA was unlikely to approve the DefenCath NDA for CRBSIs in its present form; (iii) Defendants had downplayed the true scope of the deficiencies with DefenCath's manufacturing process and/or at the facility responsible for manufacturing DefenCath; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of CorMedix Inc. (NASDAQ: CRMD) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in NASDAQ: CRMD shares over potential Wrongdoing at CorMedix Inc. here

News-ID: 2429675 • Views:

More Releases from Shareholders Foundation

ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly NASDAQ: SINA)
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made. If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: FLR) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements. Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp. (NYSE: SOC)
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp. Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc. (NASDAQ: LNTH)
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com

All 5 Releases


More Releases for CorMedix

Catheter Related Blood Stream Infection Market Growth in Future Scope 2025-2032 …
The qualitative latest Research report (2025-2032) on the Catheter Related Blood Stream Infection Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves. Request a Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/4805 Focused
Investigation announced for Long-Term Investors in shares of CorMedix Inc. (NASD …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at CorMedix Inc. Investors who purchased shares of CorMedix Inc. (NASDAQ: CRMD) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain CorMedix Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders. On July 22, 2021,
NASDAQ: CRMD Investor Notice: Update in Lawsuit against CorMedix Inc. announced
The Shareholders Foundation announced an update in the lawsuit that is pending for certain investors in shares of CorMedix Inc. (NASDAQ: CRMD). Investors who purchased shares of CorMedix Inc. (NASDAQ: CRMD) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On July 22, 2021, a lawsuit was filed against CorMedix Inc. over alleged Securities Laws Violations. The plaintiff claimed that between July 8, 2020
Catheter Related Blood Stream Infection Market to see Business Opportunities 202 …
📝Global Catheter Related Blood Stream Infection Market 2022-2028, by Drug Class (Non-antibiotic, Anti-infective, and Antimicrobial),By Pathogenesis (Contaminated Catheter Hub ,Contaminated Infusate ,Skin Insertion ,Hematogenous )By Source of Infection/Micro-organisms ( Staph. Aureus , P.aeruginsa ,CONS ,Aciento.Baumanii ,E.coli ,K. pnemoniae, Candida sp.) by Route of Administration (Oral and Intravenous), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and
Catheter Related Blood Stream Infection Market Overall Study Report 2021-2028 | …
The report examines the Catheter Related Blood Stream Infection request with respect to the assiduity trends, growth rate, prospects, motorists, conditions, pitfalls, and economic openings, by means of distinguishing the high- growth parts of the request through the colorful stakeholders. The statistical surveying study also elucidates the different strategies, collaborations, junction and accessions, product launches, inventions, and the conditioning in the R&D sector in the Catheter Related Blood Stream Infection
Deadline on Sept. 20th coming up in Lawsuit for Investors in CorMedix Inc. (NASD …
A deadline is coming up on September 20, 2021 in the lawsuit filed for certain investors of CorMedix Inc. (NASDAQ: CRMD) over alleged securities laws violations by CorMedix Inc. Investors who purchased shares of CorMedix Inc. (NASDAQ: CRMD) have certain options and there are strict and short deadlines running. Deadline: September 20, 2021. NASDAQ: CRMD stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to the